Targeted Treatment Improves Disability in Guillain-Barre Syndrome

(MedPage Today)-San Diego-a single dose of Tanruprubart has resulted in a rapid and continuous improvement in deficit compared to the imaginary drug in patients with Gilan Barry syndrome, which is the third stage, a fake study controlled …